The risk of wound-related issues was approximately 2-fold in adult patients with hidradenitis suppurativa (HS) undergoing total hip/knee arthroplasty vs those without HS.
Hidradenitis suppurativa (HS) may increase risk of wound-related complications following total joint arthroplasty, according to study findings published in Arthroplasty Today.
Although a commonly performed procedure associated with favorable efficacy and safety outcomes, certain patient factors/conditions have been implicated regarding the risk of complications following total joint arthroplasty (TJA), including total hip arthroplasty (THA) and total knee arthroplasty (TKA).
“A major push has been to investigate how more specific risk factors, especially those of rarer etiologies, affect the risk of complications following TJA,” said the study authors.
HS, a rare chronic, inflammatory disease of hair follicles, is one such condition that warrants investigation, they added. There is a lack of research to date regarding outcomes of orthopedic surgeries in patients with HS, which is more likely to occur in women and disproportionately affects Black individuals.
“[HS] skin lesions are common sites of bacterial growth and are thus a potential risk factor for infection following procedures such as THA or TKA,” noted the researchers.
They conducted a retrospective cohort study of data from the 2015-2020 PearlDiver MHip and MKnee datasets to compare rates of perioperative complications and reoperations following either THA or TKA between adult patients with HS and a matched cohort of patients without HS.
Of the study cohort, patients with HS were matched 1:4 with non-HS patients based on age, sex, and Elixhauser Comorbidity Index (ECI). The incidence of 90-day any, severe, minor, and specific adverse events was compiled and compared with multivariate analyses, and 5-year revision rates were plotted on Kaplan-Meier survival curves and compared with log-rank tests.
A total of 331,627 and 274,161 patients who underwent THA and TKA were identified, respectively, of which HS was reported for 481 (0.15%) and 290 (0.11%) patients of the 2 cohorts.
Findings of the mulvariate analyses (controlling for age, sex, and ECI) indicated that patients with HS who underwent THA had a more than 2-fold greater risk of experiencing wound dehiscence than those without HS (odds ratio [OR], 2.55; P = .002). Patients with HS vs those without who underwent TKA were also at significantly greater risk of developing surgical site infection (OR, 1.95; P = .006).
All other 90-day adverse events were not significantly different between patients with and without HS undegoing THA and TKA. No significant difference in 5-year implant survival was observed for either procedure.
“This suggests that, once through the short-term wound-related issues, implant survival should be similar for those with HS as those without HS,” said the study authors. “In the setting of little literature on this topic, this information should be helpful for patient counseling and surgical planning.”
Reference
Gouzoulis MJ, Kammien AJ, Caruana DL, Wiznia DH, Grauer JN. Hidradenitis suppurativa leads to increased risk of wound-related complications following total joint arthroplasty. Arthroplast Today. 2022 Jun 24;16:169-174. doi:10.1016/j.artd.2022.05.013
Health Equity and Access Weekly Roundup: April 27, 2024
April 27th 2024Racial disparities in end-of-life care, the role of wellness and faith in minority health, award-winning research on health disparities, societal factors impacting cardiometabolic health, and rising mental health challenges among US youth are all covered this week in the Center on Health Equity and Access.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Mental Health Diagnoses, Care Challenges Rise Among US Youth, Report Finds
April 26th 2024While behavioral health care utilization has been rising, the treatment landscape has been worsening. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial behavioral health diagnosis.
Read More